Related Experiment Video
Updated: Jan 29, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
Batoul Farran1, Samet Albayrak2, Judith Abrams1
1Department of Oncology, Wayne State University and Karmanos Cancer Institute, Detroit, Michigan.
Abstract:
Novelty and Impact Statement: Our findings suggest that soluble folate receptor (sFR) could be used in both the initial diagnosis and surveillance of patients with ovarian cancer. Our cohort constitutes one of the largest comparison groups for sFR analyzed so far. We have defined the background level of sFR using healthy volunteers. This is also the first study to prospectively follow patients in the surveillance setting to concurrently identify differential changes in tumor markers CA-125 and sFR.
More Related Videos
Related Concept Videos
Principles of Disease Surveillance
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Internal Receptors
Ovarian Cycle
Receptor-mediated Endocytosis

